Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Zogenix Inc (NASDAQ: ZGNX) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Zogenix Inc (NASDAQ: ZGNX) concerning whether a series of statements by Zogenix Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On April 8, 2019, the Company revealed it had received a refusal to file letter from the FDA regarding its new drug application for FINTEPLA, the Company's proposed treatment for seizures associated with Dravet syndrome. Furthermore, the Company revealed "the FDA determined that the [new drug application]... was not sufficiently completed to permit a substantive review... [F]irst, certain non-clinical studies were not submitted to allow assessment of the chronic administration of fenfluramine; and, second, the application contained an incorrect version of a clinical dataset, which prevented the completion of the review process that is necessary to support the filing of the [new drug application]."
Following this news, NASDAQ: ZGNX fell $11.89 or almost 23% to close at $39.96 per share on April 9, 2019.
Based in Emeryville, California, and founded in 2006 Zogenix Inc develops and commercializes therapies for the treatment of transformative central nervous system disorders in the United States.
If you purchased shares of Zogenix Inc (NASDAQ: ZGNX) on or before April 8, 2019, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185
